Rong Zhou

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Upright positioning enhances beam angle optimization and organ sparing in head and neck carbon-ion radiotherapy with fixed-beam systems.

Upright positioning enhances beam angle optimization and organ sparing in head and neck carbon-ion radiotherapy with fixed-beam systems.

Journal: Radiation oncology (London, England)
Published: July 16, 2025

CDK4/6 Inhibitor Priming Enhances PD-1 Blockade via Sellhi Neutrophil-Induced Stat5a+ Progenitor Exhausted CD8+ T Cell.

CDK4/6 Inhibitor Priming Enhances PD-1 Blockade via Sellhi Neutrophil-Induced Stat5a+ Progenitor Exhausted CD8+ T Cell.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 09, 2025

ROS-Responsive Hydrogel Delivering METRNL Enhances Bone Regeneration via Dual Stem Cell Homing and Vasculogenesis Activation.

ROS-Responsive Hydrogel Delivering METRNL Enhances Bone Regeneration via Dual Stem Cell Homing and Vasculogenesis Activation.

Journal: Advanced healthcare materials
Published: January 05, 2025

Emission of Acoustic Point Sources near an Interface.

Emission of Acoustic Point Sources near an Interface.

Journal: Physical review letters
Published: December 26, 2024

Harnessing evanescent photoacoustic waves for multi-domain imaging.

Harnessing evanescent photoacoustic waves for multi-domain imaging.

Journal: Photoacoustics
Published: November 20, 2024

FADD Functions as an Oncogene in Chr11q13.3-Amplified Head and Neck Squamous Cell Carcinoma.

FADD Functions as an Oncogene in Chr11q13.3-Amplified Head and Neck Squamous Cell Carcinoma.

Journal: Cancer research
Published: July 23, 2024

The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification.

The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification.

Journal: BMC medicine
Published: July 01, 2023

Mapping the landscape of HPV integration and characterising virus and host genome interactions in HPV-positive oropharyngeal squamous cell carcinoma.

Mapping the landscape of HPV integration and characterising virus and host genome interactions in HPV-positive oropharyngeal squamous cell carcinoma.

Journal: Clinical and translational medicine
Published: May 31, 2023

Apatinib potentiates the therapeutic effect of anti-PD-1 in locally advanced head and neck cancers.

Apatinib potentiates the therapeutic effect of anti-PD-1 in locally advanced head and neck cancers.

Journal: Oral diseases
Published: April 17, 2023

Fibroblast growth factor receptors 1 and 4 combined with lymph node metastasis predicts poor prognosis in oral cancer.

Fibroblast growth factor receptors 1 and 4 combined with lymph node metastasis predicts poor prognosis in oral cancer.

Journal: Oral diseases
Published: February 01, 2022

Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma.

Palbociclib-based high-throughput combination drug screening identifies synergistic therapeutic options in HPV-negative head and neck squamous cell carcinoma.

Journal: BMC medicine
Published: January 19, 2022

Characteristics of clinical trials of mucosal melanoma registered in WHO ICTRP

Characteristics of clinical trials of mucosal melanoma registered in WHO ICTRP

Journal: Shanghai kou qiang yi xue = Shanghai journal of stomatology
Published: December 10, 2021
Showing 1-12 of 22

Last Updated: 09/26/2026